Literature DB >> 31439427

Gene therapy for atrial fibrillation - How close to clinical implementation?

Amar Trivedi1, Jacob Hoffman1, Rishi Arora2.   

Abstract

In this review we examine the current state of gene therapy for the treatment of cardiac arrhythmias. We describe advances and challenges in successfully creating and incorporating gene vectors into the myocardium. After summarizing the current scientific research in gene transfer technology we then focus on the most promising areas of gene therapy, the treatment of atrial fibrillation and ventricular tachyarrhythmias. We review the scientific literature to determine how gene therapy could potentially be used to treat patients with cardiac arrhythmias.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Gene therapy; Genomic therapy; Ventricular tachycardia

Mesh:

Year:  2019        PMID: 31439427      PMCID: PMC6907402          DOI: 10.1016/j.ijcard.2019.07.057

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  84 in total

1.  Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer.

Authors:  Kan Kikuchi; Amy D McDonald; Tetsuo Sasano; J Kevin Donahue
Journal:  Circulation       Date:  2005-01-10       Impact factor: 29.690

2.  Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure.

Authors:  Constanze Schmidt; Felix Wiedmann; Clara Langer; Frank Tristram; Priya Anand; Wolfgang Wenzel; Patrick Lugenbiel; Patrick A Schweizer; Hugo A Katus; Dierk Thomas
Journal:  Heart Rhythm       Date:  2014-06-18       Impact factor: 6.343

3.  Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.

Authors:  Kerstin Trappe; Dierk Thomas; Olympia Bikou; Kamilla Kelemen; Patrick Lugenbiel; Frederik Voss; Rüdiger Becker; Hugo A Katus; Alexander Bauer
Journal:  Eur Heart J       Date:  2011-07-23       Impact factor: 29.983

4.  Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation.

Authors:  Nathalie Gaborit; Marja Steenman; Guillaume Lamirault; Nolwenn Le Meur; Sabrina Le Bouter; Gilles Lande; Jean Léger; Flavien Charpentier; Torsten Christ; Dobromir Dobrev; Denis Escande; Stanley Nattel; Sophie Demolombe
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

Review 5.  Gene therapy strategies for cardiac electrical dysfunction.

Authors:  Ian Greener; J Kevin Donahue
Journal:  J Mol Cell Cardiol       Date:  2010-08-07       Impact factor: 5.000

6.  Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart.

Authors:  A C Skanes; R Mandapati; O Berenfeld; J M Davidenko; J Jalife
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

Review 7.  Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.

Authors:  Ji-Youn Youn; Jun Zhang; Yixuan Zhang; Houzao Chen; Depei Liu; Peipei Ping; James N Weiss; Hua Cai
Journal:  J Mol Cell Cardiol       Date:  2013-05-02       Impact factor: 5.000

8.  Upregulation of K(2P)3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation.

Authors:  Constanze Schmidt; Felix Wiedmann; Niels Voigt; Xiao-Bo Zhou; Jordi Heijman; Siegfried Lang; Virginia Albert; Stefan Kallenberger; Arjang Ruhparwar; Gábor Szabó; Klaus Kallenbach; Matthias Karck; Martin Borggrefe; Peter Biliczki; Joachim R Ehrlich; István Baczkó; Patrick Lugenbiel; Patrick A Schweizer; Birgit C Donner; Hugo A Katus; Dobromir Dobrev; Dierk Thomas
Journal:  Circulation       Date:  2015-05-07       Impact factor: 29.690

9.  A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expression.

Authors:  D J Snyders; M M Tamkun; P B Bennett
Journal:  J Gen Physiol       Date:  1993-04       Impact factor: 4.086

10.  The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.

Authors:  Donald S Anson
Journal:  Genet Vaccines Ther       Date:  2004-08-13
View more
  5 in total

Review 1.  Surveying the Oral Drug Delivery Avenues of Novel Chitosan Derivatives.

Authors:  Iyyakkannu Sivanesan; Shadma Tasneem; Nazim Hasan; Juhyun Shin; Manikandan Muthu; Judy Gopal; Jae-Wook Oh
Journal:  Polymers (Basel)       Date:  2022-05-24       Impact factor: 4.967

Review 2.  Epigenetics in atrial fibrillation: A reappraisal.

Authors:  Rosa Doñate Puertas; Rishi Arora; Sophie Rome; Babken Asatryan; H Llewelyn Roderick; Philippe Chevalier
Journal:  Heart Rhythm       Date:  2021-01-10       Impact factor: 6.779

3.  Introducer Design Concepts for an Epicardial Parallel Wire Robot.

Authors:  Aman Ladak; Deepika Dixit; Michael S Halbreiner; Michael J Passineau; Srinivas Murali; Cameron N Riviere
Journal:  Robot Surg       Date:  2021-09-07

Review 4.  Mechanisms underlying pathological Ca2+ handling in diseases of the heart.

Authors:  Satadru K Lahiri; Yuriana Aguilar-Sanchez; Xander H T Wehrens
Journal:  Pflugers Arch       Date:  2021-01-05       Impact factor: 3.657

Review 5.  Chitosan Derivatives and Their Application in Biomedicine.

Authors:  Wenqian Wang; Qiuyu Meng; Qi Li; Jinbao Liu; Mo Zhou; Zheng Jin; Kai Zhao
Journal:  Int J Mol Sci       Date:  2020-01-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.